Blood Transfusion Diagnostics - Global Market Trajectory & Analytics

Global Blood Transfusion Diagnostics Market to Reach $4.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Blood Transfusion Diagnostics estimated at US$3.4 Billion in the year 2020, is projected to reach a revised size of US$4.7 Billion by 2027, growing at a CAGR of 4.8% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 4.4% CAGR and reach US$1.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits & Reagents segment is readjusted to a revised 5% CAGR for the next 7-year period.



The U.S. Market is Estimated at $912.8 Million, While China is Forecast to Grow at 7.2% CAGR

The Blood Transfusion Diagnostics market in the U.S. is estimated at US$912.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$944.2 Million by the year 2027 trailing a CAGR of 7.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Select Competitors (Total 42 Featured):

• Abbott Laboratories
• Bag Health Care GmbH
• Bio-Rad Laboratories, Inc.
• DiaSorin SpA
• F. Hoffmann-La Roche AG
• Grifols International SA
• Hologic, Inc.
• Immucor, Inc.
• Ortho Clinical Diagnostics, Inc.
• Quotient Ltd.